Celltrion secures CMO contract worth up to 375.4 billion won with undisclosed global pharma company, pushing Q1 cumulative orders past 1 trillion won following earlier Eli Lilly deal, as CDMO partnership inquiries surge
#YonhapInfomax #Celltrion #CMO #BiopharmaceuticalAPI #EliLilly #CDMO #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=110249
Celltrion Signs Drug Supply Deal Worth Up to 375.4 Billion Won with Global Pharma

Celltrion secures CMO contract worth up to 375.4 billion won with undisclosed global pharma company, pushing Q1 cumulative orders past 1 trillion won following earlier Eli Lilly deal, as CDMO partnership inquiries surge

Yonhap Infomax
FYI: Amazon Pharmacy adds Zepbound KwikPen at $299 as GLP-1 race heats up: Amazon Pharmacy expands access to Eli Lilly's Zepbound KwikPen at $299/month, combining transparent pricing, same-day delivery, and GLP-1 savings for U.S. customers. https://ppc.land/amazon-pharmacy-adds-zepbound-kwikpen-at-299-as-glp-1-race-heats-up/ #AmazonPharmacy #ZepboundKwikPen #GLP1 #Healthcare #EliLilly
Amazon Pharmacy adds Zepbound KwikPen at $299 as GLP-1 race heats up

Amazon Pharmacy expands access to Eli Lilly's Zepbound KwikPen at $299/month, combining transparent pricing, same-day delivery, and GLP-1 savings for U.S. customers.

PPC Land
ICYMI: Amazon Pharmacy adds Zepbound KwikPen at $299 as GLP-1 race heats up: Amazon Pharmacy expands access to Eli Lilly's Zepbound KwikPen at $299/month, combining transparent pricing, same-day delivery, and GLP-1 savings for U.S. customers. https://ppc.land/amazon-pharmacy-adds-zepbound-kwikpen-at-299-as-glp-1-race-heats-up/ #AmazonPharmacy #Zepbound #KwikPen #GLP1 #EliLilly
Amazon Pharmacy adds Zepbound KwikPen at $299 as GLP-1 race heats up

Amazon Pharmacy expands access to Eli Lilly's Zepbound KwikPen at $299/month, combining transparent pricing, same-day delivery, and GLP-1 savings for U.S. customers.

PPC Land
Business

Novo Nordisk Faces Shifting Weight-Loss Drug Market

Novo Nordisk forecasts sales drop of 5-13% in 2026 for Wegovy and Ozempic due to rivals like Eli Lilly. Learn how this affects drug prices and future growth.

#NovoNordisk, #Wegovy, #Ozempic, #WeightLossDrugs, #EliLilly

https://newsletter.tf/novo-nordisk-wegovy-sales-drop-2026-competition/

Novo Nordisk's sales are expected to drop by 5% to 13% in 2026, ending years of strong growth. This is due to new weight-loss drugs from competitors.

#NovoNordisk, #Wegovy, #Ozempic, #WeightLossDrugs, #EliLilly

https://newsletter.tf/novo-nordisk-wegovy-sales-drop-2026-competition/

Novo Nordisk's Wegovy Sales Drop 5-13% in 2026 Due to New Competition

Novo Nordisk forecasts sales drop of 5-13% in 2026 for Wegovy and Ozempic due to rivals like Eli Lilly. Learn how this affects drug prices and future growth.

Celltrion Co. has implemented measures to ensure its US business remains unaffected by any tariff policy changes, leveraging local production and inventory to maintain stable operations.
#YonhapInfomax #Celltrion #USTariffs #BranchburgPlant #EliLilly #BusinessOperations #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=106952
Celltrion Says US Tariff Issue Will Not Disrupt Business Operations in Any Scenario

Celltrion Co. has implemented measures to ensure its US business remains unaffected by any tariff policy changes, leveraging local production and inventory to maintain stable operations.

Yonhap Infomax
Novo Nordisk shares plunged 14% in pre-market trading after clinical trial data showed its new obesity drug CagriSema delivered less weight loss than Eli Lilly’s rival, prompting plans for further studies.
#YonhapInfomax #NovoNordisk #CagriSema #EliLilly #ObesityDrug #ClinicalTrialResults #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=106390
Shares in Novo Nordisk Plunge 14% as Next-Generation Obesity Drug Falls Short of Expectations

Novo Nordisk shares plunged 14% in pre-market trading after clinical trial data showed its new obesity drug CagriSema delivered less weight loss than Eli Lilly’s rival, prompting plans for further studies.

Yonhap Infomax

Three multinationals pay 46% of Ireland’s Corporation Tax.

Ireland’s fiscal watchdog has estimated that almost half of the Corporation Tax collected by the State is paid by three multinational companies.

The three multinationals are not named but they are understood to be Apple, Microsoft and pharmaceutical group Eli Lilly.

https://mediafaro.org/article/20260219-three-multinationals-pay-46-of-irelands-corporation-tax?mf_channel=mastodon&action=forward

#Ireland #CorporationTax #Business #Tax #IFA #Apple #Microsoft #EliLilly #Tech #Pharma #Pharmaceutical

Three multinationals pay 46% of Ireland’s Corporation Tax.

Ireland’s fiscal watchdog has estimated that almost half of the Corporation Tax collected by the State is paid by three multinational companies. The three multinationals are not named but they …

RTÉ